Related Experiment Video
Updated: Aug 12, 2025

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus
Anusha Govind1,2, Susana M Lazarte1,2, Ellen Kitchell1,2
1Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mpox infections can be severe and prolonged in patients with uncontrolled HIV. Delayed antiviral treatment may worsen outcomes in immunocompromised individuals with mpox.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- The mpox (monkeypox) outbreak presents a global health challenge.
- Mpox is typically self-limiting but can cause severe disease in certain populations.
Purpose of the Study:
- To describe the clinical course and outcomes of mpox in patients with uncontrolled HIV.
- To highlight the potential impact of delayed antiviral treatment on severe mpox cases.
Main Methods:
- Case series describing three patients with concurrent uncontrolled HIV and mpox infections.
- Review of clinical data, treatment initiation, and patient outcomes.
Main Results:
- Three patients with uncontrolled HIV experienced prolonged, debilitating mpox lesions lasting months.
- Despite initiating mpox antiviral and antiretroviral therapies, patients experienced severe complications and mortality.
- Delayed mpox treatment was observed in these severe cases.
Conclusions:
- Uncontrolled HIV significantly increases the risk of severe, prolonged mpox infections.
- Prompt antiviral treatment is crucial for improving outcomes in severely immunocompromised mpox patients.
- Mpox can be fatal in individuals with advanced HIV, even with treatment.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

